Literature DB >> 10993729

Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.

A C Tissot1, C Ciatto, P R Mittl, M G Grütter, A Plückthun.   

Abstract

Viral escape, first characterized for the lymphocytic choriomeningitis virus (LCMV) in a mouse transgenic for the P14 T cell-receptor (TCR), can be due to mutations in T-cell epitopes. We have measured the affinity between the H-2D(b) containing the wild-type and two of its "viral escape" epitopes, as well as other altered peptide ligands (APL), by using BIACORE analysis, and solved the crystal structure of H-2D(b) in complex with the wild-type peptide at 2.75 A resolution. We show that viral escape is due to a 50 to 100-fold reduction in the level of affinity between the P14 TCR and the binary complexes of the MHC molecule with the different peptides. Structurally, one of the mutations alters a TCR contact residue, while the effect of the other on the binding of the TCR must be indirect through structural rearrangements. The former is a null ligand, while the latter still leads to some central tolerance. This work defines the structural and energetic threshold for viral escape. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993729     DOI: 10.1006/jmbi.2000.4501

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.

Authors:  Evan M Cale; Heidi S Bazick; Tony A Rianprakaisang; S Munir Alam; Norman L Letvin
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

2.  In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.

Authors:  M T Puglielli; A J Zajac; R G van der Most; J L Dzuris; A Sette; J D Altman; R Ahmed
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  T cell receptor (TCR) clustering in the immunological synapse integrates TCR and costimulatory signaling in selected T cells.

Authors:  Bozidar Purtic; Lisa A Pitcher; Nicolai S C van Oers; Christoph Wülfing
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-09       Impact factor: 11.205

4.  Expression, refolding and crystallization of murine MHC class I H-2Db in complex with human beta2-microglobulin.

Authors:  Tatyana Sandalova; Jakob Michaëlsson; Robert A Harris; Hans-Gustaf Ljunggren; Klas Kärre; Gunter Schneider; Adnane Achour
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-11-24

5.  Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.

Authors:  Chaithanya Madhurantakam; Adil D Duru; Tatyana Sandalova; John R Webb; Adnane Achour
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

6.  New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccination.

Authors:  Masha Fridkis-Hareli; Ellis L Reinherz
Journal:  Med Immunol       Date:  2004-12-08

7.  Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.

Authors:  Jonathan M Boulter; Nicole Schmitz; Andrew K Sewell; Andrew J Godkin; Martin F Bachmann; Awen M Gallimore
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

8.  Consequences of periodic α-to-β(3) residue replacement for immunological recognition of peptide epitopes.

Authors:  Ross W Cheloha; Jeremy A Sullivan; Tong Wang; Jordan M Sand; John Sidney; Alessandro Sette; Mark E Cook; M Suresh; Samuel H Gellman
Journal:  ACS Chem Biol       Date:  2015-01-05       Impact factor: 5.100

9.  Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination.

Authors:  Adil Doganay Duru; Renhua Sun; Eva B Allerbring; Jesseka Chadderton; Nadir Kadri; Xiao Han; Kaliroi Peqini; Hannes Uchtenhagen; Chaithanya Madhurantakam; Sara Pellegrino; Tatyana Sandalova; Per-Åke Nygren; Stephen J Turner; Adnane Achour
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

10.  Antagonistic variant virus prevents wild-type virus-induced lethal immunopathology.

Authors:  Lukas Hunziker; Mike Recher; Adrian Ciurea; Marianne M A Martinic; Bernhard Odermatt; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.